Invesaro

Stocks Health care GLUC

OTC · Health care

Glucose Health, Inc. (GLUC)

Glucose Health, Inc. brought in $88.1K of revenue over the twelve months to September 30, 2017, down 70.6% from a year earlier. It posted a net loss of $94K. At September 30, 2017 it held $16.6K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 14, 2017.

Watch GLUC in 60 seconds
Price
$0.31
-22.50% on the day · September 28, 2026
52-week range $0.02 to $0.67
Market cap
$1.4M
Revenue (last 12 months)
$88.1K
-70.6% year on year
Net margin
-106.6%

What Glucose Health, Inc. does

Glucose Health, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker GLUC.

Revenue and profit by year

Revenue
FY11: $2.4K $2.4K FY11FY13: $224 $224 FY13FY14: $2.7K $2.7K FY14FY15: $4.3K $4.3K FY15FY16: $313.2K $313.2K FY16
Net income
FY11: -$632.7K -$632.7K FY11FY11: -$899.2K -$899.2K FY11FY12: -$399.1K -$399.1K FY12FY13: -$1.5M -$1.5M FY13FY14: -$669.4K -$669.4K FY14FY15: -$266.1K -$266.1K FY15FY16: -$410.4K -$410.4K FY16

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2016$313.2K-$86.6K-$410.4K-$0.15n/a
2015$4.3K-$156.2K-$266.1K-$0.14n/a
2014$2.7K-$545.2K-$669.4K-$0.99n/a
2013$224-$1.3M-$1.5M-$4.91n/a
2012n/a-$361.4K-$399.1K-$2.46n/a
2011n/a-$888.8K-$899.2K-$9.82n/a

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Glucose Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. June 28, 2023
  2. January 9, 2023
  3. September 6, 2022
  4. August 5, 2022
  5. June 1, 2022
  6. April 16, 2018
  7. April 2, 2018
  8. November 14, 2017
    Quarterly report 10-Q · period to September 30, 2017Revenue rose 1,027% to $23.8K versus the same quarter last year; diluted EPS $0.00 versus -$0.06.
  9. August 21, 2017
    Quarterly report 10-Q · period to June 30, 2017Revenue fell 88% to $34K versus the same quarter last year; diluted EPS $0.01 versus -$0.03.
  10. August 14, 2017

Recent insider filings (Forms 3, 4 and 144): 1, the latest on May 8, 2015. Insider transactions on SEC

All filings on SEC EDGAR

Questions about GLUC

What does Glucose Health, Inc. do?

Glucose Health, Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker GLUC.

Is Glucose Health, Inc. profitable?

No. Over the twelve months to September 30, 2017 it reported a net loss of $94K on revenue of $88.1K.

How much revenue does Glucose Health, Inc. make?

Over the twelve months to September 30, 2017 Glucose Health, Inc. reported revenue of $88.1K. That is 70.6% less than a year earlier.

When did Glucose Health, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 14, 2017. It covers the period to September 30, 2017. Its newest filing of any kind is the form RW filing from June 28, 2023.

Similar companies

Compare GLUC with

Compare GLUC with any company

Follow GLUC

Get an email when Glucose Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow GLUC: get an email when it files

Where the numbers come from

Financial figures are the values Glucose Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.